Novo's Clayton facility makes semaglutide, the active ingredient in Wegovy and diabetes drug Ozempic. It also does ...

Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill.

A federal appeals court on Monday rejected Novo Nordisk's challenge to the U.S. government’s program that gives its Medicare ...

Novo Nordisk has eliminated dozens of positions at its crucial Clayton, North Carolina, manufacturing plant, targeting ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Vltava Fund, an investment management company, recently released its third-quarter 2025 investor letter. A copy of the letter ...

A weight loss drug manufacturer may see layoffs at its two Johnston County facilities as it undergoes a global workforce ...

Novo Nordisk (NYSE:NVO) shares have moved little in recent sessions, with investors taking a wait-and-see approach. Market participants are weighing the company's recent performance metrics against ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Novo Nordisk is one of Europe’s largest companies and a global leader in the treatment of two major lifestyle diseases – ...

Novo Nordisk, the Danish pharmaceutical giant behind Wegovy and Ozempic, has laid off dozens of employees at its largest U.S.

Yesterday, the U.S. Court of Appeals for the Third Circuit nixed the latest challenge filed by a major pharmaceutical company ...